Search

Your search keyword '"Spinney, Richard"' showing total 118 results
Start Over Author "Spinney, Richard" Database Unpaywall
118 results on '"Spinney, Richard"'

7. Supplemental Table S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

8. Supplemental Figure S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

9. Supplemental Figure 2 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

10. Data from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

11. Supplemental Table S2 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

12. Supplemental Figure 4 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

13. Supplemental Figure 5 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

14. Supplemental Figure 5 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

15. Supplemental Table S2 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

16. Supplemental Figure Legends from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

17. Supplemental Figure 1 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

18. Supplemental Figure S2 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

20. Supplemental Figure 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

21. Supplemental Figure 5 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

22. Supplemental Figure 3 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

23. Supplemental Figure 3 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

24. Supplemental Figure 5 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

25. Data from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

27. Supplemental Figure 3 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

28. Supplemental Figure 4 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

29. Supplemental Figure 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

30. Supplemental Figure 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

31. Supplemental Figure 1 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

32. Supplemental Figure S2 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

33. Supplemental Table S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

34. Supplemental Figure 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

35. Supplemental Figure 3 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

36. Supplemental Table 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

37. Supplemental Figure S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions

Author

Han, Byungdo B., primary, Li, Suyang, primary, Tong, Meng, primary, Holpuch, Andrew S., primary, Spinney, Richard, primary, Wang, Daren, primary, Border, Michael B., primary, Liu, Zhongfa, primary, Sarode, Sachin, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, and Mallery, Susan R., primary

Published
2023
Full Text
View/download PDF

38. Supplemental Figure Legends from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

39. Supplemental Figure 4 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

40. Supplemental Table 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

41. Supplemental Table 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

42. Supplemental Figure 4 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

43. Supplemental Table 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Bissonnette, Caroline, primary, Jayawardena, Jayanetti Asiri, primary, Schwendeman, Steven P., primary, Spinney, Richard, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

44. Supplemental Figure 2 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype

Author

Mallery, Susan R., primary, Wang, Daren, primary, Santiago, Brian, primary, Pei, Ping, primary, Schwendeman, Steven P., primary, Nieto, Kari, primary, Spinney, Richard, primary, Tong, Meng, primary, Koutras, George, primary, Han, Brian, primary, Holpuch, Andrew, primary, and Lang, James, primary

Published
2023
Full Text
View/download PDF

47. Fenretinide combines perturbation of signaling kinases, cell–extracellular matrix interactions and matrix metalloproteinase activation to inhibit invasion in oral squamous cell carcinoma cells

Author

Wang, Daren, primary, Pei, Ping, additional, Shea, Fortune F, additional, Bissonnette, Caroline, additional, Nieto, Kari, additional, Din, Corrine, additional, Liu, Yayuan, additional, Schwendeman, Steven P, additional, Lin, Yan X, additional, Spinney, Richard, additional, and Mallery, Susan R, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results